American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
- PMID: 39892967
- DOI: 10.1016/j.gie.2024.10.057
American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
Erratum in
-
Erratum.Gastrointest Endosc. 2025 May;101(5):1097. doi: 10.1016/j.gie.2025.02.021. Epub 2025 Apr 23. Gastrointest Endosc. 2025. PMID: 40280699 No abstract available.
Conflict of interest statement
Disclosure The following authors disclosed financial relationships: R. Z. Sharaiha: Consultant for Boston Scientific, Olympus, Cook Medical, and Surgical Intuitive. A. P. Shukla: Consultant for Sun Pharmaceuticals; research support from Eli Lilly and Company and Novo Nordisk. D. T. Broome: Research support from Fractyl Health Laboratories, Rhythm Pharmaceuticals, Novo Nordisk, Caswell Diabetes Institute, the National Institutes of Health. N. Marya: Consultant for Boston Scientific. W. Abidi: Consultant for Boston Scientific and Ambu Inc; research support from GI Dynamics. W. W. Chan: Scientific advisory board for Regeneron Pharmaceuticals and Sanofi Pharmaceuticals. N. Thosani: Consultant for Boston Scientific Corp, Pentax America, and Ambu USA; speaker for Abbvie. A. R. Schulman: Consultant for Boston Scientific, Olympus, MicroTech, and Fractyl; research support from GI Dynamics and Fractyl. All other authors disclosed no financial relationships.
References
Publication types
LinkOut - more resources
Full Text Sources
